Literature DB >> 11928012

Is laparoscopic refundoplication feasible in patients with failed primary open antireflux surgery?

F A Granderath1, T Kamolz, U M Schweiger, M Pasiut, C F Haas, H Wykypiel, R Pointner.   

Abstract

BACKGROUND: Due to the widespread availability and acceptance of minimal-access surgery, laparoscopic antireflux surgery has become the standard procedure for the treatment of severe gastroesophageal reflux disease (GERD). However, open and laparoscopic antireflux procedures sometimes result in failure, so that redosurgery is required in some cases. The aim of this prospective study was to evaluate the surgical outcome and quality of life of patients who underwent refundoplication after the failure of primary open antireflux surgery.
METHODS: Twenty patients with a mean age of 52 years (range, 33-69) underwent laparoscopic refundoplication after primary open antireflux surgery. Four of them had undergone surgery twice previously. Preoperative and postoperative data, including esophageal manometry, 24-h pH monitoring, and assessment of quality of life, were reviewed prospectively. Quality of life was evaluated using the Gastrointestinal Quality of Life Index (GIQLI).
RESULTS: In 18 patients (90%), the reoperation was completed successfully laparoscopically. Two others (10%) required conversion to an open procedure. One of them had an injury of the gastric wall; in the other case, severe bleeding of the spleen necessitated the conversion. The average operating time was 245 min. Preoperatively, the main symptoms were recurrent reflux in 14 cases and a combination of re-reflux and dysphagia in six cases. The anatomic findings were telescope phenomenon (n = 6), hiatal disruption (n = 10), and wrap breakdown (n = 4). Postoperatively, two patients suffered from dysphagia and required pneumatic dilatation. The lower esophageal sphincter (LES) pressure increased significantly from a preoperative value of 6.08 mmHg to 12.2 mmHg at 3 months and 11.9 mmHg at 1 year after surgery. The DeMeester score decreased from a preoperative value of 69.8 to 17.1 at 3 months and 14.6 at 1 year postoperatively. The GIQLI score increased from a preoperative value of 84.9 points to 119.6 points at 3 months and 120.1 points at 1 year.
CONCLUSION: Laparoscopic refundoplication after the failure of a primary open intervention is an effective procedure that can be performed safely by experienced laparoscopic surgeon. The procedure yields excellent functional results and leads to significant improvement in the patient's quality of life.

Entities:  

Mesh:

Year:  2001        PMID: 11928012     DOI: 10.1007/s00464-001-9102-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  6 in total

1.  Long-term results of laparoscopic antireflux surgery.

Authors:  F A Granderath; T Kamolz; U M Schweiger; M Pasiut; C F Haas; H Wykypiel; R Pointner
Journal:  Surg Endosc       Date:  2002-02-08       Impact factor: 4.584

2.  Outcome of laparoscopic redo fundoplication.

Authors:  F A Granderath; T Kamolz; R Pointner
Journal:  Surg Endosc       Date:  2005-05-04       Impact factor: 4.584

Review 3.  [Relaparoscopy as an alternative to laparotomy for laparoscopic complications].

Authors:  I Leister; H Becker
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

4.  Dysphagia after laparoscopic antireflux surgery: a problem of hiatal closure more than a problem of the wrap.

Authors:  F A Granderath; U M Schweiger; T Kamolz; R Pointner
Journal:  Surg Endosc       Date:  2005-09-30       Impact factor: 4.584

Review 5.  Surgical reintervention after failed antireflux surgery: a systematic review of the literature.

Authors:  Edgar J B Furnée; Werner A Draaisma; Ivo A M J Broeders; Hein G Gooszen
Journal:  J Gastrointest Surg       Date:  2009-04-04       Impact factor: 3.452

6.  Long-term follow-up after laparoscopic refundoplication for failed antireflux surgery: quality of life, symptomatic outcome, and patient satisfaction.

Authors:  Frank A Granderath; Thomas Kamolz; Ursula M Schweiger; Rudolph Pointner
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.